Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Michael O'Riordan

November 28, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Daily News

Ischemic Heart Disease the Leading Cause of Death Globally

Michael O'Riordan

September 19, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Daily News

Genetic Study Supports Link Between Serum Calcium and CAD Risk

Todd Neale

July 26, 2017

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

Avoiding Gluten May Backfire in Terms of Coronary Risk in the General Population, Study Suggests

Todd Neale

May 11, 2017

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

News Daily News

Ship Out, Shape Up? Post-ACS Patients Not Getting Enough Physical Activity

Yael L. Maxwell

March 01, 2017

News Daily News

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Michael O'Riordan

February 03, 2017

News Features

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Michael O'Riordan

January 10, 2017

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2017

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

TCTMD’s Top 10 Most Popular Stories for September 2017

Ischemic Heart Disease the Leading Cause of Death Globally

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Genetic Study Supports Link Between Serum Calcium and CAD Risk

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

TCTMD’s Top 10 Most Popular Stories for May 2017

Avoiding Gluten May Backfire in Terms of Coronary Risk in the General Population, Study Suggests

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Ship Out, Shape Up? Post-ACS Patients Not Getting Enough Physical Activity

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content